Biolase, Inc. (BIOL) financial statements (2022 and earlier)

Company profile

Business Address 27042 TOWNE CENTRE DRIVE
FOOTHILL RANCH, CA 92610
State of Incorp. DE
Fiscal Year End December 31
SIC 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments29,97217,5645,7898,04411,6458,92411,699
Cash and cash equivalents29,97217,5645,7898,04411,6458,92411,699
Restricted cash and investments203312312312251251200
Receivables4,2383,0598,76011,11210,1249,7848,948
Inventory, net of allowances, customer advances and progress billings12,92911,15710,99512,24812,29813,52312,566
Inventory12,92911,15710,99512,24812,29813,52312,566
Prepaid expense680947     
Other current assets1,332573     
Other undisclosed current assets 1,4981,1631,5911,7321,5051,387
Total current assets:49,35435,11027,01933,30736,05033,98734,800
Noncurrent Assets
Operating lease, right-of-use asset1,7171,976276
Property, plant and equipment1,0677821,1931,9753,6744,4783,727
Intangible assets, net (including goodwill)2,9262,9262,9262,9262,9262,9262,977
Goodwill2,9262,9262,9262,9262,9262,9262,926
Intangible assets, net (excluding goodwill)      51
Other noncurrent assets220231433308334550747
Total noncurrent assets:5,9305,9154,8285,2096,9347,9547,451
TOTAL ASSETS:55,28441,02531,84738,51642,98441,94142,251
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,5859,31810,07613,49110,71814,90311,866
Accounts payable3,3092,6515,3325,9535,1099,1255,960
Accrued liabilities8,2766,6674,7447,5385,6095,7785,906
Deferred revenue2,2591,9052,237
Debt  13,466    
Deferred revenue and credits2,6253,0103,155
Customer advances and deposits2710185
Contract with customer, liability2,476
Total current liabilities:13,84411,22325,77915,96713,37018,01415,106
Noncurrent Liabilities
Long-term debt and lease obligation15,05217,960310,836  159
Long-term debt, excluding current maturities13,60316,186 10,836   
Capital lease obligations   159
Operating lease, liability1,4491,7743
Liabilities, other than long-term debt1,1801,8141,6485472501,0641,323
Deferred revenue and credits1123142
Accounts payable and accrued liabilities52138424544770773843
Deferred revenue329374358
Other liabilities3301,0561,045100169268338
Other undisclosed noncurrent liabilities  7577104798738
Total noncurrent liabilities:16,23219,7741,72611,4603541,8622,220
Total liabilities:30,07630,99727,50527,42713,72419,87617,326
Temporary equity, carrying amount25,208 3,965    
Stockholders' equity
Stockholders' equity attributable to parent25,20810,02837711,08929,26022,06524,925
Preferred stock34118     
Common stock1549831211026858
Additional paid in capital293,177261,573235,594228,430224,910201,198188,622
Accumulated other comprehensive loss(623)(385)(701)(670)(576)(876)(801)
Accumulated deficit(267,534)(251,376)(234,547)(216,692)(195,176)(178,325)(162,954)
Other undisclosed stockholders' equity(25,208)      
Total stockholders' equity: 10,02837711,08929,26022,06524,925
TOTAL LIABILITIES AND EQUITY:55,28441,02531,84738,51642,98441,94142,251

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues39,18822,78037,79946,15546,92651,81048,475
Revenue, net46,92651,81048,475
Cost of revenue(22,659)(16,607)(23,511)(29,260)(31,800)(31,502)(32,525)
Gross profit:16,5296,17314,28816,89515,12620,30815,950
Operating expenses(32,960)(24,709)(29,909)(37,780)(33,164)(35,270)(35,865)
Operating loss:(16,431)(18,536)(15,621)(20,885)(18,038)(14,962)(19,915)
Nonoperating income (expense)(338)1,835(2,278)(568)605(258)(185)
Investment income, nonoperating 4,215     
Foreign currency transaction gain (loss), before tax452(21)(121)(58)563(332)(259)
Interest and debt expense3,014(331)(188)(126)   
Loss from continuing operations before equity method investments, income taxes:(13,755)(17,032)(18,087)(21,579)(17,433)(15,220)(20,100)
Other undisclosed income (loss) from continuing operations before income taxes(2,338)331188126   
Loss from continuing operations before income taxes:(16,093)(16,701)(17,899)(21,453)(17,433)(15,220)(20,100)
Income tax expense (benefit)(65)(128)44(63)582(151)(178)
Net loss attributable to parent:(16,158)(16,829)(17,855)(21,516)(16,851)(15,371)(20,278)
Preferred stock dividends and other adjustments(546)(17,378)  (3,978)(2,184) 
Net loss available to common stockholders, diluted:(16,704)(34,207)(17,855)(21,516)(20,829)(17,555)(20,278)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(16,158)(16,829)(17,855)(21,516)(16,851)(15,371)(20,278)
Comprehensive loss:(16,158)(16,829)(17,855)(21,516)(16,851)(15,371)(20,278)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(238)316(31)(94)300(75)(244)
Comprehensive loss, net of tax, attributable to parent:(16,396)(16,513)(17,886)(21,610)(16,551)(15,446)(20,522)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: